Equity Profile

HUM

Humana Inc.

Health CareManaged Health Care$48.7B

Jul29Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Humana Inc. is a leading health care company that provides managed health care services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and attract more customers, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

HUM Q2-2026 Earnings Preview

Context

Company Snapshot

Humana Inc. is a leading health care company that provides managed health care services. With a market cap of $49 billion, it plays a crucial role in the health care sector, focusing on providing health insurance and related services to individuals and families.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+9.12%

Avg Stock Reaction

-0.09%

Last Quarter Recap

In Q1-2026, Humana reported an EPS of $10.31, exceeding estimates by 3.46%. The stock reacted positively, gaining 5.83% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the Q2-2026 earnings report, especially after a strong performance in the previous quarter. However, uncertainty remains due to the lack of analyst estimates.

Bull Case

If Humana continues to outperform expectations, particularly in EPS and revenue growth, it could lead to a significant stock price increase.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of declining membership or revenue, it could result in a sharp decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current membership enrollment figure?

Membership numbers are crucial for revenue projections and overall company growth, making this a key focus for investors.

How has the company managed costs in light of recent economic pressures?

Understanding cost management strategies will help assess the company's profitability and operational efficiency moving forward.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of cost management initiatives that Humana has implemented, which could lead to better-than-expected margins.

Supporting Evidence

Humana's recent EPS surprises indicate a trend of outperforming expectations.

The options market is pricing a significant move, suggesting that investors are anticipating volatility.

Historical performance shows that the company has a strong track record of beating EPS estimates.

Key Risk

If membership enrollment exceeds expectations, it could significantly alter the outlook for revenue growth.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the balance between revenue growth and cost management in a challenging economic environment.

Bull Confirmed If

An EPS of $10.50 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $9.50 would confirm the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±18.35%

Historical Avg

±5.8%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating heightened uncertainty around the earnings report.

Options are pricing ±18.4% while HUM has averaged ±5.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

45.5%

Calls (66K)P/C Ratio: 0.82Puts (187K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Humana beats expectations, history suggests a potential stock increase of around 5.76%, confirming strong operational performance.

In-Line / Cautious

If results are in line but cautious, the stock may see limited movement as investors await further clarity.

Miss

A miss could lead to a decline of around 12.40%, reflecting disappointment in the company's performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-LAJulia LetlowRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on membership enrollment figures and growth strategies.
2Details on cost management efforts and their impact on margins.
3Any commentary on competitive pressures in the health care market.
4Insights into future revenue projections and guidance.
5Management's outlook on economic conditions affecting operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Humana Inc. is a leading health care company that provides managed health care services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and attract more customers, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

HUM Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+9.12%

Avg Stock Reaction

-0.09%

Last Quarter Recap

In Q1-2026, Humana reported an EPS of $10.31, exceeding estimates by 3.46%. The stock reacted positively, gaining 5.83% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Humana continues to outperform expectations, particularly in EPS and revenue growth, it could lead to a significant stock price increase.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of declining membership or revenue, it could result in a sharp decline in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current membership enrollment figure?

Membership numbers are crucial for revenue projections and overall company growth, making this a key focus for investors.

How has the company managed costs in light of recent economic pressures?

Understanding cost management strategies will help assess the company's profitability and operational efficiency moving forward.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of cost management initiatives that Humana has implemented, which could lead to better-than-expected margins.

Supporting Evidence

Humana's recent EPS surprises indicate a trend of outperforming expectations.

The options market is pricing a significant move, suggesting that investors are anticipating volatility.

Historical performance shows that the company has a strong track record of beating EPS estimates.

Key Risk

If membership enrollment exceeds expectations, it could significantly alter the outlook for revenue growth.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the balance between revenue growth and cost management in a challenging economic environment.

Bull Confirmed If

An EPS of $10.50 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $9.50 would confirm the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±18.35%

Historical Avg

±5.8%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating heightened uncertainty around the earnings report.

Options are pricing ±18.4% while HUM has averaged ±5.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

45.5%

Calls (66K)P/C Ratio: 0.82Puts (187K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Humana beats expectations, history suggests a potential stock increase of around 5.76%, confirming strong operational performance.

In-Line / Cautious

If results are in line but cautious, the stock may see limited movement as investors await further clarity.

Miss

A miss could lead to a decline of around 12.40%, reflecting disappointment in the company's performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-LAJulia LetlowRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on membership enrollment figures and growth strategies.
2Details on cost management efforts and their impact on margins.
3Any commentary on competitive pressures in the health care market.
4Insights into future revenue projections and guidance.
5Management's outlook on economic conditions affecting operations.